"Concepts and Breakthroughs in Glaucoma" Conference

“青光眼的概念与突破”会议

• 批准号: 10317233
• 负责人: W Daniel Stamer
• 金额: $ 2.71万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-01 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10317233
• 关键词: Academia; Advanced Development; Area; Award; Back; Basic Science; Blindness; Cellular biology; Clinical; Clinical Research; Collaborations; Country; Development; Diagnosis; Disease; Disease Progression; Environment; Eye; Feedback; Fellowship; Fostering; Foundations; Functional disorder; Funding; Future; Glaucoma; Goals; Homeostasis; Individual; Industry; Institution; International; Learning; Location; Mentorship; Mind; Molecular; Monitor; Morehouse School of Medicine; Natural regeneration; Ophthalmologist; Optic Disk; Participant; Pathogenesis; Pathology; Patient Care; Patients; Physiologic Intraocular Pressure; Public Health; Recording of previous events; Research; Research Personnel; Reservations; Resources; Retinal Ganglion Cells; Scientist; Secure; Senior Scientist; Series; Societies; Structure; Students; Tissues; Translating; Translational Research; Translations; Travel; Underrepresented Populations; Universities; Vision; Woman; Work; career; career development; cell injury; educational atmosphere; ethnic diversity; imaging modality; interest; lectures; meetings; member; neuroprotection; new technology; novel; novel therapeutics; posters; recruit; role model; symposium; translational impact

Summary This proposal seeks support for students and junior investigators (travel awardees) to attend the 2021 Inter- national Society for Eye Research (ISER)-BrightFocus Foundation (BFF) glaucoma meeting titled "Concepts and Breakthroughs in Glaucoma" to be held October 6th-9th, 2021 in Atlanta, Georgia at the Emory Conference Center and Hotel. As was the case for the 2017 and 2019 meetings, our goal is to bring together basic scientists, clinician-scientists, students and fellows for presentations and in-depth discussions on recent excit- ing research advances and developments in molecular mechanisms underlying glaucomatous pathology, in both the conventional outflow tract and the optic nerve head. Additionally, novel technologies developed: (i) to diagnose and monitor disease progression, (ii) to modify/restore glaucomatous dysfunction, and (iii) to regen- erate damaged cells/tissues will be presented. We have already recruited 5 thought leaders in glaucoma to give keynote lectures at the conference. As with the 2017 and 2019 meetings, the platform sessions will be selected exclusively from submitted abstracts. We have reserved one platform session for travel awardees and we are again putting on a one-day "crash course" in glaucoma for people new to glaucoma and stu- dents/junior investigators, consistent with our goal of increasing participation of young scientists. ISER and BFF have an established history of promoting diversity, and the selected speakers (from abstracts) will repre- sent a diverse group of scientists that includes women and members of historically underrepresented groups. The Specific Aims of the conference are to: 1. Enhance the emerging careers of at least 30 young investigators working in glaucoma research, including women and members of underrepresented groups, by providing travel awards. 2. Provide a forum for the dissemination of the most recent advances in glaucoma research. 3. Create an environment that will facilitate the exchange of novel ideas among basic and clinician scientists, and which will generate the opportunity for vision scientists with diverse personal and scientific back- grounds to meet and establish research collaborations. 4. Bring together scientists working in disparate areas of glaucoma research. We anticipate that this meeting will provide state-of-the-art information on recent advances in glaucoma and will serve as an important resource for those involved in the translation of these findings into novel therapeu- tics. This conference will also provide new opportunities, avenues for new discovery, and a forum to develop potential collaborations among the attendees. The requested funds will support the travel, accommodation and registration of 18 students (pre- and postdoctoral) and 12 junior investigators who otherwise would not have the resources to attend this focused meeting.

总结 这项建议旨在支持学生和初级研究人员（旅行获奖者）参加2021年国际 国家眼科研究学会（ISER）-眼科焦点基金会（BFF）青光眼会议，题为“概念 2021年10月6日至9日在格鲁吉亚亚特兰大市埃默里会议上举行的”青光眼和青光眼的突破性进展“ 中心和酒店与2017年和2019年的会议一样，我们的目标是将基本的 科学家，临床科学家，学生和研究员的演讲和深入讨论最近的兴奋， 综述了肿瘤病理学基础分子机制的研究进展和发展， 传统的流出道和视神经乳头。此外，开发的新技术： 诊断和监测疾病进展，（ii）改变/恢复昏迷性功能障碍，和（iii）再生- 将呈现受损的细胞/组织。我们已经招募了5位青光眼领域的思想领袖， 在会议上作主题演讲。与2017年和2019年的会议一样，平台会议将 仅从提交的摘要中选出。我们已预留一个平台环节予旅游奖得主 我们再次为青光眼和青光眼的新患者举办为期一天的青光眼“速成班”， 这与我们增加年轻科学家参与的目标一致。ISER和 BFF在促进多样性方面有着悠久的历史，选定的演讲者（来自摘要）将代表- 派出了一个多元化的科学家小组，其中包括妇女和历史上代表性不足的群体的成员。 会议的具体目标是： 1.促进至少30名从事青光眼研究的年轻研究人员的新兴职业，包括 妇女和任职人数不足群体的成员提供旅行奖励。 2.为青光眼研究的最新进展提供一个传播论坛。 3.创造一个有利于基础科学家和临床科学家之间交流新思想的环境， 这将为视觉科学家带来机会，他们有着不同的个人和科学背景， 以满足和建立研究合作的理由。 4.汇集了在青光眼研究的不同领域工作的科学家。 我们预计，这次会议将提供有关青光眼最新进展的最新信息， 将成为那些参与将这些发现转化为新疗法的人的重要资源。 抽搐本次会议还将提供新的机会，新发现的途径，以及发展的论坛。 与会者之间的潜在合作。申请的资金将用于支付差旅费、住宿费、 和注册18名学生（前和博士后）和12名初级研究人员，否则他们不会 有足够的资源来参加这次重点会议。